Theralink Technologies Inc THER
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $8.00 Mil
- Volume/Avg
- 8.5 Mil / 1.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 7.77
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Theralink Technologies Inc is a proteomics-based, precision medicine and molecular profiling company that specializes in patented Reverse Phase Protein Array (RPPA) and protein biomarker assay services that target multiple areas of oncology. The company provides precision oncology data through its Theralink Reverse Phase Protein Array (RPPA) assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to both FDA-approved and investigational drug treatments. The firm is currently generating revenue with its multiple biopharma contracts and by testing breast cancer patients with its patented Theralink assay.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 16
- Website
- https://www.theralink.com
Valuation
|
Metric
|
THER
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 7.77 |
Price/Cash Flow | — |
Price/Earnings
THER
Financial Strength
|
Metric
|
THER
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.00 |
Interest Coverage | 0.31 |
Quick Ratio
THER
Profitability
|
Metric
|
THER
|
|---|---|
Return on Assets (Normalized) | −1,121.52% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
THER
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Qmdgnkzgl | Vyfz | $562.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Wqbvmnjq | Pwxdjq | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Dpwgpwhsj | Dvjzts | $99.5 Bil | |
MRNA
| Moderna Inc | Wlsdzgl | Mws | $38.8 Bil | |
ARGX
| argenx SE ADR | Wskgqkqw | Bqjmc | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Krvsnhmw | Hzy | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Tjhzctsm | Vvkjqz | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Gfcrxpcbm | Tjfzc | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Gjtwyfqmg | Cwbrwbz | $12.5 Bil | |
INCY
| Incyte Corp | Qhygcwjv | Xzykywx | $11.6 Bil |